Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Psychoactive Substances
Hans H. Maurer, Simon D. Brandt
Handbook of experimental pharmacology (2018)
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
Vera L. Alves, João Gonçalves, Joselin Aguiar, et al.
Critical Reviews in Toxicology (2020) Vol. 50, Iss. 5, pp. 359-382
Closed Access | Times Cited: 157
2-Phenethylamines in Medicinal Chemistry: A Review
Carlos T. Nieto, Alejandro Manchado, Leland Belda, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 855-855
Open Access | Times Cited: 33
Chemical classification of new psychoactive substances (NPS)
Félix Zapata, José Manuel Matey, Gemma Montalvo, et al.
Microchemical Journal (2020) Vol. 163, pp. 105877-105877
Closed Access | Times Cited: 52
Amphetamine-type stimulants analysis in oral fluid based on molecularly imprinting extraction
A. Sorribes-Soriano, Francesc A. Esteve‐Turrillas, Sergio Armenta, et al.
Analytica Chimica Acta (2018) Vol. 1052, pp. 73-83
Closed Access | Times Cited: 49
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
Philipp Klahn
Antibiotics (2020) Vol. 9, Iss. 6, pp. 297-297
Open Access | Times Cited: 31
Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood
Arianna Giorgetti, Rossella Barone, Guido Pelletti, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 2, pp. 202-223
Open Access | Times Cited: 27
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
Arianna Giorgetti, Jennifer P. Pascali, Paolo Fais, et al.
Life (2021) Vol. 11, Iss. 5, pp. 440-440
Open Access | Times Cited: 21
Simulated 2017 nationwide sampling at 13,940 major U.S. sewage treatment plants to assess seasonal population bias in wastewater-based epidemiology
Olga E. Hart, Rolf U. Halden
The Science of The Total Environment (2020) Vol. 727, pp. 138406-138406
Closed Access | Times Cited: 23
Piloting the UK’s First Home-Office-Licensed Pharmacist-Led Drug Checking Service at a Community Substance Misuse Service
Amira Guirguis, Rosalind Gittins, Fabrizio Schifano
Behavioral Sciences (2020) Vol. 10, Iss. 8, pp. 121-121
Open Access | Times Cited: 23
Application of Microextraction-Based Techniques for Screening-Controlled Drugs in Forensic Context—A Review
Samir M. Ahmad, Oriana C. Gonçalves, Mariana N. Oliveira, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2168-2168
Open Access | Times Cited: 19
The novel psychoactive substances epidemic: A scientometric perspective
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, et al.
Addiction Neuroscience (2022) Vol. 5, pp. 100060-100060
Open Access | Times Cited: 13
Structure determination of butylone as a new psychoactive substance using chiroptical and vibrational spectroscopies
Dita Spálovská, František Králík, Michal Kohout, et al.
Chirality (2018) Vol. 30, Iss. 5, pp. 548-559
Closed Access | Times Cited: 20
Interpol review of controlled substances 2016–2019
Nicole S. Jones, Jeffrey H. Comparin
Forensic Science International Synergy (2020) Vol. 2, pp. 608-669
Open Access | Times Cited: 18
Development and validation of a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method including 25 novel synthetic opioids in hair and subsequent analysis of a Swiss opioid consumer cohort
Max Polke, Marta Concheiro, Gail Cooper, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 11, pp. 1384-1391
Open Access | Times Cited: 2
Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports
Liam Engel, Sascha Thal, Stephen Bright, et al.
Journal of Psychedelic Studies (2024)
Open Access | Times Cited: 2
LC‐MS/MS method for the quantification of new psychoactive substances and evaluation of their urinary detection in humans for doping control analysis
Eulàlia Olesti, José A. Pascual, Mireia Ventura, et al.
Drug Testing and Analysis (2020) Vol. 12, Iss. 6, pp. 785-797
Closed Access | Times Cited: 15
Designer benzodiazepines versus prescription benzodiazepines: can structural relation predict the next step?
Raneem Moustafa, Fuad Tarbah, Huda Sulaiman Saeed, et al.
Critical Reviews in Toxicology (2021) Vol. 51, Iss. 3, pp. 249-263
Closed Access | Times Cited: 12
Cannabinoids as multifaceted compounds
Diana Persia, Francesca Mangiavacchi, Maria Carla Marcotullio, et al.
Phytochemistry (2023) Vol. 212, pp. 113718-113718
Open Access | Times Cited: 5
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances
C. Ramos, Amira Guirguis, Nigel Smeeton, et al.
Brain Sciences (2020) Vol. 10, Iss. 3, pp. 142-142
Open Access | Times Cited: 12
Ultraviolet-Visible and High-Resolution Mass Spectrometry for the Identification of Cyclopropyl-Fentanyl in the First Fatal Case in Spain
José Manuel Matey, Carmen García‐Ruiz, Gemma Montalvo, et al.
Journal of Analytical Toxicology (2020)
Open Access | Times Cited: 12
Screening suspect pharmaceuticals for illicit designer benzodiazepines using raman, SERS, and FT-IR prior to comprehensive analysis using LC-MS
Martin M. Kimani, Skyler W. Smith, Adam Lanzarotta, et al.
Forensic Science International (2022) Vol. 338, pp. 111390-111390
Closed Access | Times Cited: 8
Assessment of NMDA receptor inhibition of phencyclidine analogues using a high-throughput drebrin immunocytochemical assay
Toshinari Mitsuoka, Kenji Hanamura, Noriko Koganezawa, et al.
Journal of Pharmacological and Toxicological Methods (2019) Vol. 99, pp. 106583-106583
Open Access | Times Cited: 11
A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues
Arianna Giorgetti, Michaela J. Sommer, Maurice Wilde, et al.
Forensic Toxicology (2021) Vol. 40, Iss. 1, pp. 180-188
Open Access | Times Cited: 8
Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
Sergei Gavryushov, Anton Bashilov, Konstantin Cherashev-Tumanov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14874-14874
Open Access | Times Cited: 3
Determination of 19 Psychoactive Substances in Premortem and Postmortem Whole Blood Samples Using Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry
Sevasti Karampela, Jessica A. Smith, Irene Panderi
Separations (2021) Vol. 8, Iss. 6, pp. 78-78
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top